Insight

Marco Tagliamento: What might be platinum backbone in immunotherapy-containing regimens for lung cancer

Marco Tagliamento/LinkedIn

Oct 15, 2024, 12:53

Marco Tagliamento: What might be platinum backbone in immunotherapy-containing regimens for lung cancer

Marco Tagliamento, Assistant Professor at University of Genoa, shared a post on X:

“In Annals of Oncology we discussed what might be the best platinum backbone in immunotherapy-containing regimens for lung cancer, including clinical and biological reasons.

Time to rethink platinum choices in the era of immunotherapy in lung cancer

Authors: E. Harris, N.F. Taflin, A. Chitkara, M. Tagliamento, C.M. Bestvina, C.V. Vakkalagadda, B. Besse, R. Thawani.“

A. Chitkara Annals of Oncology B. Besse C.M. Bestvina C.V. Vakkalagadda cancer E. Harris Lung cancer M Tagliamento Marco Tagliamento N.F. Taflin OncoDaily Oncology R. Thawani

Oncologist Near Me - Vivek Subbiah: Pionner of Precision Oncology

Monica Bertagnolli is ending her tenure as NIH director

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success

Special Coverage